📰 Rhinitis News
Page 8 - Rhinitis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rhinitis. Real-time updates on events, politics, business and more.
December 21, 2021
In this interview, Carol Stonham, the head of a Locality Based FeNO referral service, talks to NewsMed about measuring airway inflammation when diagnosing and treating asthma patients.
December 3, 2021
Studies like this give us hope that we will be able to prevent food allergies, said one allergy specialist who was not involved in the study.
December 3, 2021
Wisdom and for some reason he doesnt even want to entertain where this started. and go over what went wrong. unless comes to blaming. also, what was buried in that interview with margaret brennan on sunday. is he taking credit for coming up with the vaccine. i got together with all the leading scientists and said we have got to come up with vaccine. no publicly you were saying vaccine is two years away. until recently you werent even talking about the vaccine until it came to market. steve: obvi...
December 1, 2021
- Results from ALK-sponsored REACT (REAl-world effeCTtiveness of allergy immunotherapy) study have been published in The Lancet Regional Health - Europe - REACT demonstrated the real-world
December 1, 2021
HAMILTON, BERMUDA / ACCESSWIRE / December 1, 2021 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection
December 1, 2021
People with allergic conditions such as hay fever, rhinitis, and atopic eczema, may have a lower risk of COVID-19 infection, especially if they also have asthma, finds a large, population-based study of UK adults, published online in the respiratory journal Thorax.
November 4, 2021
In a recent interview, Microsoft founder Bill Gates, a longtime advocate for pandemic preparedness, gave concrete suggestions for steps we should be taking.
September 30, 2021
Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, has received marketing approval for its fixed-dose combination nasal
May 3, 2021
Photo Credit: IANS IANSLive Chennai, May 3 (IANS) Pharma major Glenmark Pharmaceuticals Limited on Monday announced the launch of Ryaltris-AZ nasal spray for the treatment of moderate to severe allergic rhinitis, in India. To get full access of the story, click here to subscribe to IANS News Service © 2021 IANS India Private Limited. All Rights Reserved. The reproduction of the story/photograph in any form will be liable for legal action. For news, views and gossips, follow IANS at Twitter. ...
May 3, 2021
Chennai: Pharma major Glenmark Pharmaceuticals Limited on Monday announced the launch of Ryaltris-AZ nasal spray for the treatment